CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,291 | -18.4% | 43,838 | -9.6% | 0.00% | -20.0% |
| Q2 2023 | $1,582 | +12.8% | 48,503 | +21.7% | 0.01% | 0.0% |
| Q1 2023 | $1,402 | -9.3% | 39,851 | +18.1% | 0.01% | -16.7% |
| Q4 2022 | $1,546 | -99.9% | 33,747 | -6.8% | 0.01% | -14.3% |
| Q3 2022 | $1,754,000 | +27.6% | 36,205 | +3.5% | 0.01% | +16.7% |
| Q2 2022 | $1,375,000 | +67.1% | 34,989 | +56.6% | 0.01% | +100.0% |
| Q1 2022 | $823,000 | -20.4% | 22,348 | -1.5% | 0.00% | -25.0% |
| Q4 2021 | $1,034,000 | +46.7% | 22,686 | +15.1% | 0.00% | +33.3% |
| Q3 2021 | $705,000 | +108.0% | 19,716 | +15.0% | 0.00% | +50.0% |
| Q2 2021 | $339,000 | -18.5% | 17,139 | -4.3% | 0.00% | 0.0% |
| Q1 2021 | $416,000 | +6.1% | 17,911 | -5.1% | 0.00% | 0.0% |
| Q4 2020 | $392,000 | – | 18,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |